![]() |
Volumn 46, Issue 12, 2002, Pages 3392-3396
|
Increased cutaneous reactions to hydroxychloroquine (Plaquenil) possibly associated with formulation change: Comment on the letter by Alarcón [3]
a,b
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMITRIPTYLINE;
CARBAMAZEPINE;
CLOBETASOL PROPIONATE;
CLOMIPRAMINE;
COTRIMOXAZOLE;
ENALAPRIL;
FLUOXETINE;
HYDROXYCHLOROQUINE;
IBUPROFEN;
LANSOPRAZOLE;
LISINOPRIL;
METHYLPREDNISOLONE ACETATE;
MORPHINE;
NAFTIDROFURYL OXALATE;
NAPROXEN;
PENICILLIN G;
PRAVASTATIN;
RANITIDINE;
ROFECOXIB;
STEROID;
TAMOXIFEN;
TRAMADOL;
WARFARIN;
ADULT;
ALOPECIA;
ANTIPHOSPHOLIPID SYNDROME;
CLINICAL ARTICLE;
DISCOID LUPUS ERYTHEMATOSUS;
DRUG FORMULATION;
DRY SKIN;
EXFOLIATION SYNDROME;
HAIR DISEASE;
HUMAN;
LETTER;
PRIORITY JOURNAL;
PRURITUS;
RASH;
SJOEGREN SYNDROME;
SKIN MANIFESTATION;
STEVENS JOHNSON SYNDROME;
SYSTEMIC LUPUS ERYTHEMATOSUS;
URTICARIA;
|
EID: 0036899794
PISSN: 00043591
EISSN: None
Source Type: Journal
DOI: 10.1002/art.10565 Document Type: Letter |
Times cited : (22)
|
References (11)
|